SepctraMax i3x Multi Mode Microplate Detection Platform (Toxicology)

The contract involves the procurement of a SpectraMax i3x Multi-Mode Microplate Detection Platform, specifically intended to support research in the hepatotoxicity area under the HFP priority. This acquisition is managed by the Food and Drug Administration (FDA) and falls under the NAICS code 541990, which pertains to specialized services. The contract is currently forecasted rather than solicited, with no specific solicitation number or detailed location information provided for performance. Key contacts for this contract include the HFP Acquisition Liaison, reachable via a designated FDA email, while the contracting officer has yet to be assigned. The equipment will enhance toxicology research capabilities within the FDA, supporting critical investigations into liver toxicity, a significant factor in drug safety assessment. Further details and updates are available through the FDA’s official industry opportunity forecast portal.